MORGAN STANLEY - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$49,880,467
+2.4%
961,088
+18.3%
0.01%0.0%
Q2 2023$48,724,816
+23.7%
812,622
+2.0%
0.01%
+25.0%
Q1 2023$39,378,515
+94.5%
796,491
+124.5%
0.00%
+100.0%
Q4 2022$20,243,984
+188.0%
354,722
+136.9%
0.00%
+100.0%
Q3 2022$7,029,000
+707.0%
149,750
+541.4%
0.00%
Q2 2022$871,000
+1144.3%
23,347
+892.6%
0.00%
Q1 2022$70,000
+45.8%
2,352
+67.4%
0.00%
Q4 2021$48,000
-44.2%
1,405
-39.5%
0.00%
Q3 2021$86,000
+8500.0%
2,321
+11505.0%
0.00%
Q2 2021$1,000
-99.8%
20
-99.9%
0.00%
Q1 2021$648,00015,2070.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$24,560,0004.02%
Rock Springs Capital Management LP 2,292,285$97,583,0002.13%
RTW INVESTMENTS, LP 1,245,532$50,142,0000.78%
Avidity Partners Management LP 550,000$23,414,0000.65%
Samsara BioCapital, LLC 80,000$3,406,0000.63%
Bain Capital Public Equity Management II, LLC 300,871$12,808,0000.53%
GENERAL ATLANTIC, L.P. 950,000$40,442,0000.47%
Baker Brothers Advisors 2,520,730$107,307,0000.46%
Perceptive Advisors 400,000$17,028,0000.22%
Pinz Capital Management, LP 18,700$796,0000.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders